losartan has been researched along with Hypernatremia in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Hypernatremia: Excessive amount of sodium in the blood. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Della Penna, SL | 1 |
| Rosón, MI | 1 |
| Toblli, JE | 1 |
| Fernández, BE | 1 |
1 review available for losartan and Hypernatremia
| Article | Year |
|---|---|
Role of angiotensin II and oxidative stress in renal inflammation by hypernatremia: benefits of atrial natriuretic peptide, losartan, and tempol.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic N-Oxides; Humans; Hypernatremia; Losartan | 2015 |